Showing results (471-480 of 488) with videos related to
Sort By:
Pageof 49
Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.International Journal of Oncology|July 19, 2008
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experienceKrzysztof Mrózek, Andrew J Carroll, Kati Maharry, et al.Cancer Research|January 13, 1998
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogeneticsM A Caligiuri, M P Strout, D Lawrence, et al.Leukemia|January 12, 2017
Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral bloodThomas M Herndon, Shih-Shih Chen, Nakhle S Saba, et al.Blood|October 14, 2010
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemiaYair Herishanu, Patricia Pérez-Galán, Delong Liu, et al.Journal of Medicinal Chemistry|August 11, 2015
Development of Selective Covalent Janus Kinase 3 InhibitorsLi Tan, Koshi Akahane, Randall McNally, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunityDan H Barouch, Maria G Pau, Jerome H H V Custers, et al.Iscience|February 24, 2022
Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon responseDylan G Ryan, Elena V Knatko, Alva M Casey, et al.Blood|October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.Pageof 49